📰 Micron News
Page 110 - Micron News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Micron. Real-time updates on events, politics, business and more.
February 17, 2023
The recommendation is based on clinical data for Moderna's bivalent Omicron-targeting COVID-19 vaccine, mRNA.1273.214Moderna's bivalent Omicron-targeting COVID-19 vaccines (mRNA.1273.214 (BA.1) & mRNA.1273.222
February 16, 2023
In a recent study posted to the medRxiv* preprint server, researchers provided quantitative estimates of population-level drivers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission and infection severity by fitting coronavirus disease 2019 (COVID-19) epidemiological surveillance data from England into dynamic transmission models.
February 16, 2023
In a recent study published in the journal JAMA Network Open, researchers determined new-onset diabetes, hypertension, and hyperlipidemia, all cardiometabolic disorders in adult coronavirus disease 2019 (COVID-19) patients under treatment in California, United States of America (USA) between March 2020 and June 2022.
February 16, 2023
Researchers examine non-hospitalized adult patients with COVID-19 treated with nirmatrelvir-ritonavir.
February 16, 2023
Researchers evaluated the effectiveness of nirmatrelvir–ritonavir in preventing coronavirus disease 2019 (COVID-19) severity outcomes during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant predominance.
February 16, 2023
Researchers performed a retrospective population-wide cohort study using anonymized data in Hong Kong, China, between February 26 and July 3, 2022.
February 15, 2023
It appears that the tsunami of layoffs that started late last year is starting to accelerate. January was a horrible month for job losses, and major layoff announcements are coming fast and [...]
February 15, 2023
A meta-analysis on the long-term vaccine effectiveness of four COVID-19 vaccines.
February 15, 2023
Investigators in the Smidt Heart Institute at Cedars-Sinai have confirmed that people who have had COVID-19 have an increased risk for new-onset diabetes-;the most significant contributor to cardiovascular disease.
February 15, 2023
The National Institutes of Health has initiated a multi-site clinical trial evaluating an investigational antiviral for the treatment of COVID-19.